Martlet Capital: why we backed Kalium Health
Martlet Capital is a Cambridge-based, early stage investor and one of our earliest backers. In this short Q&A series, we asked Peter...
Martlet Capital: why we backed Kalium Health
From UK to USA: How we’re thinking about international growth
Forging effective medtech-pharma partnerships
Introducing our advisory board
US healthcare leader joins UK medtech as it launches Series A raise
Awards shortlisting marks pivotal moment for Kalium Health
Unlocking future talent
Kalium shortlisted for 2023 OBN Award
Partnering to drive innovation in chronic disease management
Cambridge spinout advances towards clinical evaluation after R&D success
Kalium Health secures A4I grant funding to drive sensor innovation
Visit our labs on Cambridge Wide Open Day 2023